Russia patents its second vaccine against COVID-19, called EpiVacCorona

For Anthony Fauci, a coronavirus vaccine could be available before the end of the year

The main US specialist warned that the amount of doses that may be available in December will not be "enough to vaccinate everyone" and...

The number of coronary infections rose sharply in Europe, Italy rebel against restrictions – this is how the coronary situation developed in the world...

During the week, record numbers of coronary infections were recorded in more than 20 European countries. Strong restrictive measures were introduced in several...

After escaping from Venezuela, the opposition leader Leopoldo López is already in Spain

Venezuelan opposition leader Leopoldo López arrived in Madrid this Sunday after clandestinely leaving your country where he was a refugee for 18 months in...

Biden would bring the short leash back into the world

The other day, it has become clear that if the Democratic presidential candidate wins on 3 November, another world will welcome in, and that...

Opposition member who fled from Venezuela arrived in Spain

Prominent Venezuelan opposition politician Leopoldo López arrived in the Spanish capital Madrid on Sunday, the Spanish Ministry of Foreign Affairs announced in a statement.López...

Russia has patented its second vaccine against COVID-19, developed by the State Research Center for Virology and Biotechnology Véktor and called EpiVacCorona, as reported on Wednesday by the Federal Intellectual Property Service (Rospatent).

Rospatent experts have completed the second round examination of applications for inventions related to the vaccine against the coronavirus SARS-CoV 2. The State Research Center for Virology and Biotechnology Véktor received patents for the vaccine it created against COVID-19, “the agency said in a statement.

The EpiVacCorona contains synthetic peptide antigens, virus fragments.The vaccine based on these antigens generates an immune response and contributes to the development of immunity against COVID-19, Rospatent noted.

The Russian Government foresees register your second vaccination on October 15, phase II of clinical trials ended today. The first Russian vaccine, Sputnik V, was registered on August 11 and is currently in phase III trials, the first results of which are expected in October or November.

Meanwhile, Russia is experiencing a new increase in coronavirus cases and amounted to 8,481 new cases in the last 24 hours. In Moscow, the focus of the pandemic in the country, There were 2,308 new cases of COVID-19 in the last day. The mayor of the Russian capital, Sergei Sobianin, has recommended that those over 65 stay at home and that companies return to teleworking, and has ordered the closure of schools in the city for two weeks.

.

trending

Related Articles